Chronic hepatitis virus infection in children

Area of Science:

• Pediatrics
• Hepatology
• Infectious Diseases

Background:

• Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are primary causes of chronic liver disease in children.
• HBV transmission occurs perinatally from HBeAg-positive mothers or horizontally via contaminated needles and intrafamilial spread.
• HCV infection in children is linked to blood product exposure, maternal infection, and unsterile needles in endemic areas.

Purpose of the Study:

• To review the epidemiology, transmission, and management of HBV and HCV infections in pediatric populations.
• To highlight the impact of immunization programs and current challenges in preventing viral hepatitis in children.

Main Methods:

• Review of existing literature on pediatric HBV and HCV infections.
• Analysis of transmission routes, natural history, and clinical outcomes.
• Evaluation of the effectiveness of current prevention strategies.

Main Results:

• Universal HBV immunization has drastically reduced carrier rates and hepatocellular carcinoma incidence in children.
• Spontaneous HBeAg/anti-HBe seroconversion in HBV infection is rare in young children, increasing with age.
• Mother-to-infant HCV transmission occurs in about 5% of cases, influenced by maternal viral load; genotype Ib is most common.
• Chronicity develops in 60-80% of pediatric HCV cases, often with minimal liver histology changes.

Conclusions:

• While HBV immunization is highly effective, ongoing vigilance and research are needed for HCV prevention, particularly for mother-to-infant transmission.
• Vaccine development for HCV is crucial to reduce pediatric infections and long-term liver disease.
• Screening of blood products has reduced HCV transmission, but other routes require continued attention.